Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. - PubMed - NCBI

JAMA. 2008 Nov 12;300(18):2134-41. doi: 10.1001/jama.2008.623. Epub 2008 Nov 9. Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't